Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Academic
|
| gptkbp:applies_to |
gptkb:Medicine
gptkb:Public_health Pharmaceuticals |
| gptkbp:challenges |
Regulatory compliance
Drug safety Drug efficacy |
| gptkbp:collaborated_with |
gptkb:Non-profit_organizations
Government agencies Healthcare professionals |
| gptkbp:contributes_to |
Patient safety
Health outcomes Drug policy |
| gptkbp:focuses_on |
Pharmacology
|
| gptkbp:has_applications_in |
Health education
Disease prevention Drug therapy |
| https://www.w3.org/2000/01/rdf-schema#label |
Drug Science
|
| gptkbp:includes |
Toxicology
Clinical trials Drug development Drug regulation |
| gptkbp:involves |
Data analysis
Ethical considerations Research methodologies |
| gptkbp:is_essential_for |
gptkb:Public_health
Patient care Medical advancements |
| gptkbp:is_influenced_by |
gptkb:Scientific_research
Technological advancements Public health policies |
| gptkbp:is_practiced_in |
Clinical researchers
Pharmacologists Toxicologists |
| gptkbp:is_related_to |
gptkb:Medicine
gptkb:Chemistry gptkb:Biology |
| gptkbp:is_studied_in |
Universities
Research institutes |
| gptkbp:is_supported_by |
Research institutions
Regulatory agencies Pharmaceutical companies |
| gptkbp:originated_in |
New discoveries
Changing regulations Emerging diseases |
| gptkbp:published_by |
Scientific journals
|
| gptkbp:bfsParent |
gptkb:Professor_Sir_David_Nutt
|
| gptkbp:bfsLayer |
6
|